Skip to main content
Home
  • Home
  • About us
    • Principal Investigators
    • Project Members
    • Executive Board
    • Scientific Advisory Board
    • Governance & Committees
    • Management & Communication
    • Institutions & Cooperations
  • Research
    • Project Area A
    • Project Area B
    • Project Area C
    • Core Projects
    • Former Projects
    • Publications
  • Public Outreach
  • Careers
    • Equal opportunities
    • Careers Committee
  • News
  • Events
    • Events archive
  • Internal
    • Recorded Seminars
    • Corporate identity
    • Internal grant opportunities
    • Internal review
    • Guidelines PhD
    • Toolbox repository
    • Neutrophil encyclopedia
    • INF services

Neutrophil Regulation of Immunotherapy for Cancer Is Controlled by Type II Interferon


  1. Neutrophil Regulation of Immunotherapy for Cancer Is Controlled by Type II Interferon
A2
Z1

Pei, S.; Pan, Y.; Liang, H.; Lei, L.; Lin, Q.; Mi, J.; Ravetch, J. V.; Soehnlein, O.; Karlsson, M. C. I.

2026 Immunity
https://doi.org/10.1016/j.immuni.2026.05.014

Footer menu

  • Privacy Policy
  • Site Notice
  • Home
  • About us
    • Principal Investigators
    • Project Members
    • Executive Board
    • Scientific Advisory Board
    • Governance & Committees
    • Management & Communication
    • Institutions & Cooperations
  • Research
    • Project Area A
    • Project Area B
    • Project Area C
    • Core Projects
    • Former Projects
    • Publications
  • Public Outreach
  • Careers
    • Equal opportunities
    • Careers Committee
  • News
  • Events
    • Events archive
  • Internal
    • Recorded Seminars
    • Corporate identity
    • Internal grant opportunities
    • Internal review
    • Guidelines PhD
    • Toolbox repository
    • Neutrophil encyclopedia
    • INF services